Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX2XBZ
|
||||
| Drug Name |
(1S,2R,3R)-1-(6-Chloro-2,3-dihydro-1H-pyrrolo[3',4':4,5]imidazo[1,2-a]pyridine-2-sulfonylamino)-2-methyl-3-phenylcyclopropanecarboxylic Acid
|
||||
| Synonyms |
CHEMBL1767003
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H19ClN4O4S
|
||||
| Canonical SMILES |
C[C@@H]1[C@H](c2ccccc2)[C@]1(NS(=O)(=O)N3Cc4nc5cc(Cl)ccn5c4C3)C(=O)O
|
||||
| InChI |
InChI=1S/C20H19ClN4O4S/c1-12-18(13-5-3-2-4-6-13)20(12,19(26)27)23-30(28,29)24-10-15-16(11-24)25-8-7-14(21)9-17(25)22-15/h2-9,12,18,23H,10-11H2,1H3,(H,26,27)/t12-,18-,20+/m1/s1
|
||||
| InChIKey |
CPYCKLJBTHKVRT-LIUKBUMOSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Interstitial collagenase | Target Info | [1587926] | ||
| Matrix metalloproteinase-14 | Target Info | [1587926] | |||
| Pathway Interaction Database | Endothelins | ||||
| Validated transcriptional targets of AP1 family members Fra1 and Fra2 | |||||
| Glucocorticoid receptor regulatory network | |||||
| AP-1 transcription factor network | |||||
| Syndecan-1-mediated signaling eventshif2pathway:HIF-2-alpha transcription factor network | |||||
| Signaling events mediated by focal adhesion kinase | |||||
| WikiPathways | TGF beta Signaling Pathway | ||||
| Bladder Cancer | |||||
| Activation of Matrix Metalloproteinases | |||||
| Degradation of collagen | |||||
| Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis | |||||
| Oncostatin M Signaling Pathway | |||||
| Prostate Cancer | |||||
| Integrated Breast Cancer Pathway | |||||
| Integrated Cancer pathway | |||||
| Cell surface interactions at the vascular wall | |||||
| Matrix MetalloproteinasesWP615:Senescence and Autophagy in Cancer | |||||
| AGE/RAGE pathway | |||||
| Matrix Metalloproteinases | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.